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Infectious diseases respect no species or
geographic boundaries. For a parasite, closely
related hosts offer new environments in which
infection, maintenance, replication, and trans-
mission remain possible. The anthropoid
primates (which include humans) and to a
lesser degree simian primates share broadly
similar physiologic and genetic characteristics
and thus susceptibility to many viruses,
bacteria, fungi, protozoa, helminths, and
ectoparasites (1) that have the potential to
cross primate-species boundaries (2).
Similarities in pathogen susceptibility have
made nonhuman primates ideal laboratory
models. During the 20th century, laboratory
research on captive primates has elucidated the
life cycle and pathogenesis of many infectious
agents and facilitated drug and vaccine develop-
ment. Nevertheless, the ecology of infectious
agents found in wild populations of primates has
only recently been addressed. Just as captive
primates have proved invaluable for research at
the level of the organism, wild populations can
provide the opportunity to study infectious
disease phenomena at the population and
ecosystem levels. Research at these levels
addresses such pressing questions as the
origin(s) of pathogens, determinants of pathogen
emergence, and factors influencing maintenance
of pathogens in animal reservoirs.
During the past two decades unknown
human diseases, including AIDS, Ebola fever,
hantavirus infection, and dengue hemorrhagic
fever, have emerged from enzootic foci. The
emergence of these and other diseases has been
linked to the interface of tropical forest communi-
ties with high levels of biodiversity and agricultural
communities with relative genetic homogeneity
and high population densities of humans, domestic
animals, and crops. This interface poses a high risk
for the emergence of novel disease (3-5).
Since most nonhuman primates live in
tropical forest habitats, most interactions
between humans and wild nonhuman primates
occur in this high-risk interface, which has
recently increased because of expanded ecotourism
and forest encroachment. These interactions can
lead to pathogen exchange through various
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routes of transmission (Table). Arthropod
vectors, shared water, and hunting of wild
animals have facilitated pathogen exchange and
may have played an important role in pathogen
transfers since ancient times. In the recent past,
laboratory research has led to accidental human
exposure to such agents as primate malaria
parasites (12) and a simian immunodeficiency
virus (SIV) (16). The potential for exchange
through xenotransplantation has been discussed
(17), and infection from vaccine contaminated
with SV40, a primate papovavirus, led to the
exposure of millions of persons in the 1950s (15).
Conversely, pathogen transmission from humans
to nonhuman primates places both captive and
wild animals at serious risk for diseases such as
measles and tuberculosis (TB), which are deadly
in many nonhuman primate species. In general,
as levels of interaction increase, so does pathogen
exchange, resulting in further risks to both
humans and nonhuman primates.
The need for improved surveillance and basic
research on emerging infectious disease is well
documented (3,18-20). Wild primates can serve as
sentinels by signaling which pathogens pose a
risk for humans in the immediate area (21) as
well as in distant countries (5). Here, we describe
potential benefits of incorporating wild popula-
tions into emerging infectious disease research.
Pathogen Origins
Nonhuman primates are infected with the
closest relatives of important human pathogens.
The construction of molecular phylogenies has
played an important role in studying the
evolution and classification of many pathogens.
While trees that result from these analyses must
be interpreted with care, they can provide
valuable information on the history of pathogens.
Furthermore, the selection of genes that are
evolving at the appropriate rate should allow
phylogenetic analyses to assess both ancient and
more recent epidemic origins (22).
Human herpes simplex virus infection is
common in nonhuman primates and may reflect
contact with humans. A study of viral infection in
nonhuman primates found that chimpanzees and
gorillas were seropositive to human herpes
simplex virus-1 and -2 strains, but orangutans
and gibbons were not (23).
Research on SIV phylogeny (24,25) has
shown that HIV-1 and HIV-2 are each more
closely related to primate pathogens than they
are to one another. HIV-1 is in a group with
SIVCPZ (26), a chimpanzee (Pan troglodytes) virus,
while HIV-2 falls within a clade consisting of
West African primate viruses (Figure 1; 24). In
fact, Mindell (27) has argued that HIVs and SIVs
should be referred to as ‘primate immunodefi-
ciency viruses’ to more accurately reflect their
heritage. Preliminary evidence suggests that the
origins of global T-cell lymphotropic virus-1
subtype diversity may be analogous, leading Liu et
al. (28) to propose that HTLV-I subtypes emerged
from three separate nonhuman primate reservoirs.
This pattern is not unique to viruses, as
demonstrated through decades of research on
primate malarias. More than 26 species of
Plasmodia infect primates (12,29). Both morpho-
logic and molecular analyses show human and
Table. Routes of pathogen exchange between human and nonhuman primates
Route of exchange Pathogen Direction of exchange Evidencea Reference
Animal bite Herpes B Nonhuman primate to human E   6b
Monkeypox Nonhuman primate to human E   7
Fecal-oral Poliovirus Human to nonhuman primate L   2b
Poliovirus Chimpanzee to chimpanzee E   8
Hunting, food prep & eating Ebola Nonhuman primate to human E   9
Nasal secretions Mycobacterium leprae Among primates P, L 10b
Respiratory droplet Tuberculosis Human to nonhuman primate L 11b
Vector-borne Malaria Both directions L,E 12b
Filaria Both directions L,E   8b
Water-mediated Dracunculiasis Human to nonhuman primate L 13
Schistosomiasis Nonhuman primate to human E 14
Xenotransplantation SV40 Nonhuman primate to human Ec 15b
aL = laboratory; E = epidemiologic ; P = evidence that parasites live naturally in multiple primate hosts.
bEvidence reviewed.
cThe only current evidence for xenotransplantation includes SV40 spread through vaccine production.151 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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nonhuman primate malarias interdigitating on
phylogenetic trees (Figure 2; 30,33). Preliminary
evidence suggests that this group of parasites has
a range of coevolutionary scenarios, including the
speciation of P. vivax and related parasites in
Asian primates, the recent exchange of parasites
between humans and New World monkeys (30),
and perhaps an ancient exchange of a falciparum-
like parasite from a bird or lizard to an African
hominoid (31,34,35). Further analyses are likely
to lead to surprises. For example, recent research
has shown that the diversity of human P. vivax
(previously considered to be a single species) also
includes a P. vivax-like parasite, a wide-
spread pathogen, which is most closely
related to P. simiovale, a primate malaria of
Asian macaques (Macaca sp.) (30,36).
A major limitation of these studies is that they
rely on very small numbers of nonhuman primate
isolates—only two SIVcpz isolates for the HIV-1
clade, a single P. simiovale isolate for malaria
phylogeny. In addition, very few data are available
on the distribution of these pathogens in wild
populations; more data on the distribution and
extent of shared pathogens should provide clues to
origins (37), thereby pointing to general conditions
that may contribute to disease emergence.
Molecular phylogenies can also play a direct
role in the control of pathogens, for example, in
charting their antigenic diversity, a task
necessary for vaccine design (38). Because
nonhuman primate pathogens are often evolu-
tionary outgroups, vaccines that are targeted at
antigens shared by human and nonhuman
pathogens should provide more universal
coverage. Molecular phylogenies can also assist
in determining the rate of evolution of vaccine
candidate antigens. Because low rates of
mutation often indicate selective constraint, this
technique may point to candidate antigens that
cannot easily mutate to evade vaccine-induced
antibodies. Similar analyses identifying highly
constrained gene products or metabolic pathways
as targets for drug development may contribute
to slowing the emergence of drug resistance.
Reservoirs
The study of pathogen transmission has been
encumbered by the use of inappropriate
Figure 1. Relationships among primate and human
lentiviruses: Phylogeny of primate lentiviruses based
on the gag gene obtained by (25).  The names of the
strains are indicated in parentheses. Hosts are
indicated on trees. The description of the lentivirus
strains is provided in (25).
Figure 2. Relationships between primate and human
parasites: Malaria phylogeny based on the
circumsporozoite protein gene. The alignment does not
include the central repeat region. P. falciparum (Pfa), P.
vivax (Pvi), and P. malariae (Pma) are from humans; P.
cynomolgi (Pcy), P. simiovale (Pso), and P. knowlesi (Pkn)
are from macaques; P. simium (Psi) and P. brasilianum
(Pbr) are from New World monkeys;  P. reichenowi (Pre)
is from chimpanzees; P. gallinacium (Pga) is from birds;
and P. berghei (Pbe) and P. yoelii (Pyo) are from rodents.
The numbers in the names indicate different isolates as
described in (30). The sequence of P. gallinacium was
reported by (31). The numbers on the branches are
bootstrap % based on 500 pseudoreplications. The tree
was estimated by the neighbor-joining method with the
Tajima and Nei distance (32).152 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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terminology. Such terms as “primary hosts,”
“reservoir hosts,” “carriers,” “arthroponoses,”
“xenonoses,” and “zoonoses” pose premature
assumptions and belie aspects of the origins and
natural transmission cycles of pathogens. The
factors that determine pathogen viability within
a vertebrate host may correspond only roughly,
or not at all, to species boundaries. Primate
pathogens do not adhere to the faithfully
maintained sanctity of the distinction between
humans and nonhumans.
The misconception of an evolutionary trend
toward increasing host specificity (39) has
contributed to the belief that pathogen exchange
should be rare. An apparently restricted host
range, however, may be the product of specific
ecologic conditions and not of an intrinsic
characteristic of the pathogen. In many cases,
ecologic changes can broaden the host range of a
pathogen. For example, the filarid worm Loa loa
remains outside human populations, primarily
because of vector behavior (40); changes in
ecology, such as the availability of a novel host,
can change vector behavior and expand the
pathogen’s host range. Similar phenomena may
have played a role in the emergence of a range of
flaviviruses (e.g., yellow fever, dengue, and
Japanese encephalitis) from primarily forest-
dwelling nonhuman primate cycles. For these
flaviviruses, primate populations may also
continue to play a role by introducing novel
genetic variants, which, at least in the case of
dengue, may be involved in pathogenesis.
Another misconception is that primate
populations are too sparse to maintain human
pathogens. A number of variables influence
whether or not a pathogen is maintained in a
given population. The capacity for latency, for
example, may decrease the host population size
necessary to maintain pathogens. This character-
istic has evolved independently in pathogens as
diverse as herpesviruses and Plasmodium and
may help explain sustained transmission in hosts
with low population density. Orangutans (Pongo
pygmaeus), for example, are thought to act as
hosts to two distinct Plasmodium species (41),
despite an estimated population size of two per
km2. While molecular phylogenies have not yet
been used to verify that these parasites are
unique, the presence of a dormant hypnozoite
stage might allow for sustained transmission
even at this extreme. Where human and
nonhuman hosts overlap, both must be factored
into epidemiologic models. Small populations of
nonimmune humans alone may not be capable of
maintaining a pathogen, but when nearby
nonhuman hosts are considered, a critical
population size may be reached.
Surveys to assess pathogen prevalence
among nonhumans can play an important role in
control strategies. Eradication programs must
consider animal reservoirs; even if complete
human coverage is achieved, long-term reemer-
gence from animal reservoirs can undo the best
eradication efforts. For example, it is not known if
poliovirus infections can be maintained in
nonhuman primate populations. Seroprevalence
surveys conducted before and after eradication
may prove invaluable.
Accidental exposure to infected laboratory
workers has led to poliovirus infections of
chimpanzees and gorillas since the 1940s (1).
Poliovirus can infect not only our closest living
relatives, chimpanzees, gorillas (Gorilla gorilla),
and orangutans (Pongo pygmaeus) (2), but also
more distantly related anthropoids like the
colobus monkeys (e.g., Colobus abyssinicus
kikuyuensis [=guereza]) (42). Antibodies and shed
virus have also been found in recently imported
animals (8), and some chimpanzees may act as
symptomless carriers (2). Long-term research by
Jane Goodall on wild Tanzanian chimpanzees
documented the potential for transmission of
poliovirus (or a similar virus) in free-ranging
chimpanzee populations (43). Since no samples
were collected, it is impossible to determine if the
epidemic described by Goodall was part of a
natural chimpanzee cycle or the result of
introduction from local human populations or
researchers. As poliovirus eradication efforts
intensify, it may be useful to monitor virus
prevalence in humans living near primate habitats.
Control efforts that rely on antimicrobial
drugs must also take into account the potential
for nonhuman primate reservoirs. Despite
demonstrations that mass administration of
diethylcarbamazine citrate successfully con-
trolled  Brugia malayi (a filarid worm), Mak et al.
found a high prevalence of B. malayi after a
large-scale administration of chemotherapy
(44). Research showed that even though
periodic prevalence of B. malayi decreased,
subperiodic prevalence remained high. The
maintenance of subperiodic B. malayi was
eventually attributed to mosquitoes infected by
leaf monkeys (Presbytis obscura). In this153 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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particular free-ranging primate host, approxi-
mately 83% of the monkeys were infected (44).
Nonhuman “reservoirs” may also confer
potential benefits. It is at least theoretically
possible that nonhuman primate populations
may provide a barrier to the spread of drug-
resistant pathogens; while these pathogens
benefit from resistance in environments where
drug pressure exists, drug resistance can be
costly, and resistant pathogens may not compete
effectively against susceptible ‘wild-type’ patho-
gens in the absence of drug pressure. As drug-free
populations, reservoirs may provide havens for
susceptible pathogens, thereby decreasing the
rate at which drug-resistant genes spread and
increasing the rate at which susceptibility may
return after drug pressure ends. This hypothesis
may help explain why the rates of drug-resistant
gram-negative enteric bacteria of wild baboons
(Papio cynocephalus) living with limited human
contact are significantly lower than those of
baboons living with human contact (45).
Sentinel Surveillance
In tropical lowland forests, which contain the
greatest biodiversity of terrestrial habitats (46),
exist rarely seen or unknown pathogens with the
potential to enter human populations. These
pathogens may affect residents of and visitors to
forested regions (21) and act as the source of
introduction of infectious agents to distant
susceptible populations (47). Increasing human
contact with forested systems almost certainly
leads to a corresponding increase in the
emergence of infections in the human population.
Nevertheless, predicting which pathogens hu-
mans may encounter and be susceptible to
remains a methodologic challenge.
Surveillance methods for predicting emerg-
ing pathogens include surveillance of vectors or
forest-dwelling human populations and wildlife
epidemiology (epidemiologic study of infections
in wild populations) (48). These approaches have
limitations. While vector sampling may prove the
easiest method for widespread surveillance, the
pathogens identified from vectors may be difficult
or impossible to culture. Even when successful,
vector sampling is likely to identify a range of
pathogens, only some of which may infect humans.
Studies of human populations, while providing
valuable information, are limited to regions in
which forest-dwelling human populations exist.
Epidemiologic research among free-ranging
primate populations has the potential to predict
which pathogens might enter human populations
as contact with forested regions increases. In
addition to their physiologic similarities to
humans, primates have other characteristics that
contribute to their accumulation of infectious
agents. Primates live primarily in forested
environments (49); in general, they have large
bodies and live in large groups—characteristics
that may attract vectors (50). Furthermore,
dependence on fruit, a characteristic of most
primates, requires mobility (both terrestrially
and arboreally), a trait that may increase
exposure to pathogens (51,52).
Despite the lack of organized attempts to
document the distribution of pathogens in wild
populations, recognized “die-offs” in wild primate
populations have played an important role in
identifying novel pathogens. In 1956, for
example, a novel flavivirus was identified
through the investigation of large-scale deaths of
bonnet macaques (Macaca radiata) and hanuman
langurs (Presbytis entellus) in the Kyanasur
Forest of India (Seymour, 1981, cited in [2])
caused by Kyanasur Forest virus. More recently,
in 1995, deaths in a chimpanzee population
studied by Christoph Boesch in the Täi Forest,
Côte d’Ivoire, and a single human case following a
necropsy led to the identification of a novel strain
of Ebola virus (9,53). The single human case in
the Swiss researcher foreshadowed the localized
mini-outbreak of Ebola hemorrhagic fever in
Mayibout, a village in the northeast of Gabon in
January 1996. The Gabon epidemic was linked to
the handling, preparation, and consumption of a
chimpanzee that had been found dead; 29 of 37
identified cases involved exposure to the dead
chimpanzee (54). Close monitoring of such
populations, as is being conducted in the Täi
Forest, has the potential to identify emergence-
linked behavior, such as the consumption of
specific plants or insects, which may lead to the
still elusive reservoir of Ebola virus. Considering
the exceptionally small percentage of wild
primate populations under long-term study,
these examples represent only the tip of the
iceberg. More systematic monitoring of wild
primate populations will likely provide a
substantial payoff in our understanding, identifi-
cation, and possible control of novel pathogens,
both for humans and endangered primates.154 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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Surveillance for certain types of human-
nonhuman primate contact may be particularly
useful. Hunting, which involves tracking,
capturing, handling, transporting, preparing,
and consuming meat, may play a particularly
important role in pathogen exchange. In addition
to the recent evidence of hunting-mediated Ebola
transmission, the hunting of a red colobus
(Colobus pennanti oustaleti [=badius]) has been
implicated in a localized epidemic of monkeypox,
an orthopoxvirus similar to smallpox, which
continued for four generations of human-to-
human contact (55). Another example is the
increased risk for feline plague among cats that
hunt rodents (7). Necropsies share many
characteristics with hunting and are appropri-
ately considered a high-risk activity.
Bites from wild primates may also play a role
in the transmission of certain pathogens. For
example, chimpanzee-to-human transmission of
monkeypox occurred when a wild chimpanzee bit
a 2-year-old girl (6). Further sampling demon-
strated high prevalence in forest squirrel
populations (up to 49% among Funisciurus
lemniscatus) (56), underlining the need for
comprehensive studies before determining the
ultimate source and reservoir of pathogens. Bites
and scratches have transmitted pathogens to
laboratory workers. The transmission of B-virus,
a herpesvirus infecting rhesus macaques (Macaca
mulatta), has caused death in 18 of 24 known
human cases (57). Surveillance and education in
human populations that hunt nonhuman pri-
mates, as well as follow-up of reported primate
bites in nonlaboratory settings, may be indicated.
Ecologic and Social Factors Involved in
Natural Transmission
The potential for disease emergence and
reemergence depends on the interaction of
complex social, ecologic, and genetic factors at the
host, vector, and pathogen levels (58). Because
wild populations of primates display diverse
social behavior and live in a range of ecologic
environments, they exemplify natural transmis-
sion. Furthermore, monitoring pathogens in wild
primate populations does not involve the
treatment or behavior change interventions that
monitoring pathogens in humans requires.
Exceptions include the increasingly common
need for wildlife medicine to maintain the health
of endangered species and decrease the impact of
pathogens from humans and domestic animals on
free-ranging animals (59). Nevertheless, for
many pathogens, basic epidemiologic research,
and not treatment, remains the primary goal of
wildlife medicine (59).
Studies of wild populations can highlight
factors associated with the pathogen exchange
across species boundaries. Some parasites, for
example, the chewing lice–pocket gopher system,
complete their entire life cycle on a single host.
This high level of host specificity may contribute
to the close cospeciation between pocket gophers
and their respective lice; the phylogenetic trees of
host and parasite are nearly mirror images (60).
Nevertheless, such host-specific parasites may be
the exception rather than the rule. Many
intestinal parasites, for example, seem to be
generalists. One epidemiologic study of wild
primates in the Kibale Forest National Park,
Uganda, evaluated the role of primate distribu-
tion on the distribution of intestinal amoebas
(61); the park contains a number of spatially
separate primate groups, each of which consists
of multiple primate species. Most variation in
amoeba prevalence was explained by group
membership, and little was explained by species,
which suggests that these parasites treated the
primate groups as biologic islands (62), spreading
easily among diverse members of the same island
but rarely spreading to new islands.
Long-term behavioral research combined
with occasional pathogen sampling may provide
valuable data. Long-term research on the SIVs of
East African primates, for example, has provided
evidence for a recent cross-species transmission
of SIV between baboons and African grivet
monkeys (Cercopithecus aethiops aethiops) (62).
This research has documented the incidence of
SIVagm among Ethiopian grivet monkeys for more
than 20 years (63). By examining prevalence in
age groups over time, this research demonstrated
the minimal impact of SIVagm on the survival of
grivets, the predominance of sexual transmis-
sion, and the lack of maternal transmission.
An ecologic approach to pathogen transmis-
sion can benefit our understanding of emerging
diseases. By determining how humans become a
part of the life cycle of pathogens rather than how
pathogens enter human populations, we can
better understand the factors associated with
emergence and improve the quality of public
health responses. How humans become part of
the life cycle of pathogens depends on human
migrations, environmental changes, and cultural155 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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and social factors, in the context of evolutionary
history of the pathogens, vectors, and hosts,
which make up an infectious system. Ecologic and
evolutionary studies of wild animals in general, and
primate populations in particular, can address
questions arising from these complex interactions.
The Future
Traditionally, the study of wild populations of
primates has been the domain of primatologists
and wildlife veterinarians, who have worked to
overcome logistic difficulties in the field, develop
methods, and address ethical issues. Opportuni-
ties exist for collaborative work on infectious
disease; the benefits of such efforts are
considerable. The translocation of animals from
vulnerable forest fragments to forest reserves, an
increasingly common conservation effort, is an
opportunity for pathogen sampling. Other
possibilities are provided by collaboration with
long-term behavioral research on free-ranging
animals. While behavioral research sites may
only provide fecal and urine samples, the study of
intestinal parasites is often possible; recent
advances in urinalysis demonstrate that urine
may be a source of both antigen and antibody
from systemic infections, such as malaria (64).
The distribution of appropriate necropsy proto-
cols and sample collection kits would improve
data collection and decrease risks associated with
necropsies. Urgently needed are strategies for
noninvasive remote diagnosis. For example,
combined with sensitive molecular diagnostics, a
remote tissue-biopsy dart system (65) may have
potential for obtaining epidemiologic samples.
Efforts to preserve endangered primates and
monitor disease emergence have some common
objectives. Pathogen exchange is a two-way
street, and exposure to human pathogens poses a
serious threat to endangered animals (11). While
the main focus of this article has been risk to
humans, nonhuman primates are frequently more
threatened by microorganisms indigenous to
humans than vice versa (2). TB, which is often fatal
to nonhuman primates, represents a serious threat
to laboratory primate communities, which com-
monly are infected by humans and can occasionally
reinfect laboratory workers (66). TB is prevalent in
wild populations, as demonstrated by the presence
in wild olive baboons (Papio cynocephalus) of
Mycobacterium bovis infection, an infection that
most likely originated from cattle (67).
Both hunting and forest encroachment
threaten endangered primates and increase the
possibility of human and nonhuman infectious
disease emergence. Research on the pathogens of
primates and humans on forest boundaries helps
assess risks to wild primates and to humans. In
addition to their value in the study of infectious
disease and human evolution, many primates are
valuable natural resources in their home
countries. The veterinary expertise and wildlife
management skills of conservation organizations
can both supplement the basic pathogen research
and control work of the public health community
and benefit from it.
The examination of pathogen exchange in
regions of host overlap may identify social factors
that influence pathogen emergence. Data on
forest use by human communities surrounding
forest reserves and levels of crop-raiding by
nonhuman primates have been collected as part
of ongoing conservation projects. A comparison of
these data with human and nonhuman primate
pathogen prevalence may provide a measure of
forest-oriented behavioral risks. Further re-
search comparing infection rates among hunters
and nonhunters could confirm the findings and
determine the role of behavioral control
measures to decrease risk.
Much remains to be done. Recent evidence
has suggested that some wild primates self-
medicate with plants in their environment (68).
An understanding of the underlying wildlife
epidemiology, therefore, combined with long-
term dietary data and analysis of plant
chemistry, may lead to new chemotherapeutic
drugs (69). In addition, research on the dynamics
of primate pathogens in their natural hosts may
elucidate novel host resistance mechanisms. In
particular, evidence of impaired host survival
and reproduction, as well as long-term host-
parasite association, may point to hosts that are
likely to have evolved genetically mediated
resistance. Such resistance mechanisms in
humans (70) have begun to play an increasingly
important role in vaccine and drug development
(71,72). While the findings from captive primate
studies have played an important role in
medicine in the 20th century, this period has also
been marked by a notable absence of research on
the basic ecology of disease systems. Perhaps by
learning from primates in their natural environ-
ments we may better prepare ourselves for the156 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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disease threats to humans and wildlife popula-
tions in the coming century.
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